Pediatrics

Pediatrics Research

Overview

Our goal at the Center for Pediatric Research is to create the future of pediatric health care through research and data analysis to improve clinical performance and quality of care. We seek to increase the ability of AdventHealth for Children to become a leading children’s network and to extend the healing ministry of Christ.

AdventHealth for Children has over 135 highly skilled pediatric specialists covering more than 35 pediatric sub-specialties currently providing consultation services to the unit. Comprehensive sub-specialty care includes the Johns Hopkins Children’s Heart Surgery program, a Level IV Comprehensive Pediatric Epilepsy Center, Level III Neonatal Intensive Care Unit (NICU), Cancer and Blood Disorder specialty with a pediatric bone marrow transplant program, a Pediatric Liver Transplant program, and a Complex Care Clinic for patients with complex diagnoses. Interdisciplinary rounds occur every day on each patient. 

AdventHealth for Children has been recognized for excellence in nursing by being awarded Magnet status in 2012 and re-designation in 2016. AdventHealth for Children has been recognized by U.S. News & World Report as the Best Children’s Hospital for newborn care in Florida for the second year in a row.

Contact Information

Center for Pediatric Research

Areas of Focus

  • Asthma
  • Autism
  • Cardiology
  • Dermatology
  • Hematology
  • Hepatology
  • Neonatology 
  • Orthopedics
  • Rheumatology and Immunology
  • Sepsis (infections)
  • Pediatric obesity
  • Urology
  • Vaccines

Featured Clinical Trials

NCT05470985

A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants with Moderately to Severely Active Crohn’s Disease with an Inadequate Response to Conventional Therapy

Icon for trial | IM047023 A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants with Moderately to Severely Active Crohn’s Disease with an

The purpose of this study is to see whether ozanimod (RPC1063, also referred to as the ‘study drug’ or ‘study treatment’) is safe and effective for the possible treatment of Crohn’s Disease (CD) in a pediatric population. To do ...

NCT05093634

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study: 5 Independent Sub-studies of Setmelanotide in Patients with POMC, PCSK1, LEPR, SRC1, SH2B1, and PCSK1 N221D Gene Defects in the Melanocortin-4 Receptor Pathway

Icon for trial | RM-493-035 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study: 5 Independent Sub-studies of Setmelanotide in Patients with POMC, PCSK1, LEPR, SRC1, SH2B1, and PCSK1 N221D Gene Defects in the Melanocortin-4 Receptor Pathway

This study is currently enrolling.

Appetite (feeling of hunger and feeling of being full after eating) and weight can be controlled by certain genes located in the brain. These genes are part of the Melanocortin-4-Receptor pathway (MC4R). Sometimes there is a ge ...

Meet the Team

Regino Gonzalez-Peralta

Regino Gonzalez-Peralta, MD

Pediatric Gastroenterologist

Full Bio
Miles Landis

Miles Landis, MD

Pediatrician

Full Bio

Our Capabilities

  • 82 licensed beds in Women’s Hospital
  • 20 beds in Children’s Hospital
  • 2 neonatal transport teams 
  • 12 neonatologists and a dedicated interdisciplinary team (pharmacists, nutritionists, clinical social workers, nurse discharge coordinators, speech therapists, occupational/physical therapists, lactation consultants, and child life specialists)